Vocal Biomarkers Market Segment: Targeting Neurology and Psychiatry
The Vocal Biomarkers Market segment most developed today is neurology, where biomarkers are applied to conditions like Parkinson’s and Alzheimer’s disease. Psychiatry follows closely, with applications in detecting stress, depression, and anxiety disorders.
These segments are growing as healthcare systems demand efficient ways to monitor cognitive decline and mental health conditions. Expansion into respiratory and cardiovascular applications is also expected, widening the market reach.
FAQ
Q1: What is the largest application segment?A1: Neurology is the largest segment due to its proven effectiveness in detecting neurodegenerative disorders.
Q2: Which segment is growing fastest?A2: Psychiatry, given the global rise in mental health awareness.
2 Views